270 related articles for article (PubMed ID: 16515509)
1. Immune response to pre-erythrocytic stages of malaria parasites.
Doolan DL; Martinez-Alier N
Curr Mol Med; 2006 Mar; 6(2):169-85. PubMed ID: 16515509
[TBL] [Abstract][Full Text] [Related]
2. IL-12 and NK cells are required for antigen-specific adaptive immunity against malaria initiated by CD8+ T cells in the Plasmodium yoelii model.
Doolan DL; Hoffman SL
J Immunol; 1999 Jul; 163(2):884-92. PubMed ID: 10395683
[TBL] [Abstract][Full Text] [Related]
3. The complexity of protective immunity against liver-stage malaria.
Doolan DL; Hoffman SL
J Immunol; 2000 Aug; 165(3):1453-62. PubMed ID: 10903750
[TBL] [Abstract][Full Text] [Related]
4. Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.
Overstreet MG; Cockburn IA; Chen YC; Zavala F
Immunol Rev; 2008 Oct; 225():272-83. PubMed ID: 18837788
[TBL] [Abstract][Full Text] [Related]
5. Antigen export during liver infection of the malaria parasite augments protective immunity.
Montagna GN; Beigier-Bompadre M; Becker M; Kroczek RA; Kaufmann SH; Matuschewski K
mBio; 2014 Jul; 5(4):e01321-14. PubMed ID: 25073641
[TBL] [Abstract][Full Text] [Related]
6. T cells as mediators of protective immunity against liver stages of Plasmodium.
Tsuji M; Zavala F
Trends Parasitol; 2003 Feb; 19(2):88-93. PubMed ID: 12586477
[TBL] [Abstract][Full Text] [Related]
7. Direct processing and presentation of antigen from malaria sporozoites by professional antigen-presenting cells in the induction of CD8 T-cell responses.
Plebanski M; Hannan CM; Behboudi S; Flanagan KL; Apostolopoulos V; Sinden RE; Hill AV
Immunol Cell Biol; 2005 Jun; 83(3):307-12. PubMed ID: 15877610
[TBL] [Abstract][Full Text] [Related]
8. Interferon-γ--central mediator of protective immune responses against the pre-erythrocytic and blood stage of malaria.
McCall MB; Sauerwein RW
J Leukoc Biol; 2010 Dec; 88(6):1131-43. PubMed ID: 20610802
[TBL] [Abstract][Full Text] [Related]
9. Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell Responses.
Doll KL; Pewe LL; Kurup SP; Harty JT
J Immunol; 2016 May; 196(10):4253-62. PubMed ID: 27084099
[TBL] [Abstract][Full Text] [Related]
10. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
[TBL] [Abstract][Full Text] [Related]
11. Memory T cells maintain protracted protection against malaria.
Krzych U; Zarling S; Pichugin A
Immunol Lett; 2014 Oct; 161(2):189-95. PubMed ID: 24709142
[TBL] [Abstract][Full Text] [Related]
12. TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites.
Pichugin A; Steers N; De La Vega P; Zarling S; Chalom I; Krzych U
Eur J Immunol; 2016 Apr; 46(4):885-96. PubMed ID: 26703789
[TBL] [Abstract][Full Text] [Related]
13. Immune effector mechanisms in malaria.
Good MF; Doolan DL
Curr Opin Immunol; 1999 Aug; 11(4):412-9. PubMed ID: 10448141
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
[TBL] [Abstract][Full Text] [Related]
15. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
[TBL] [Abstract][Full Text] [Related]
16. Immunization with apical membrane antigen 1 confers sterile infection-blocking immunity against Plasmodium sporozoite challenge in a rodent model.
Schussek S; Trieu A; Apte SH; Sidney J; Sette A; Doolan DL
Infect Immun; 2013 Oct; 81(10):3586-99. PubMed ID: 23836827
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity differs between routes of administration of attenuated malaria parasites independent of parasite liver load.
Haeberlein S; Chevalley-Maurel S; Ozir-Fazalalikhan A; Koppejan H; Winkel BMF; Ramesar J; Khan SM; Sauerwein RW; Roestenberg M; Janse CJ; Smits HH; Franke-Fayard B
Sci Rep; 2017 Sep; 7(1):10372. PubMed ID: 28871201
[TBL] [Abstract][Full Text] [Related]
18. Tissue-specific cellular immune responses to malaria pre-erythrocytic stages.
Silvie O; Amino R; Hafalla JC
Curr Opin Microbiol; 2017 Dec; 40():160-167. PubMed ID: 29217460
[TBL] [Abstract][Full Text] [Related]
19. Class II-restricted protective immunity induced by malaria sporozoites.
Oliveira GA; Kumar KA; Calvo-Calle JM; Othoro C; Altszuler D; Nussenzweig V; Nardin EH
Infect Immun; 2008 Mar; 76(3):1200-6. PubMed ID: 18160479
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.
Sack BK; Keitany GJ; Vaughan AM; Miller JL; Wang R; Kappe SH
PLoS Pathog; 2015 May; 11(5):e1004855. PubMed ID: 25974076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
